These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 19485794

  • 1. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M, Timm J.
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [Abstract] [Full Text] [Related]

  • 2. Telaprevir: a new hope in the treatment of chronic hepatitis C?
    Fowell AJ, Nash KL.
    Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
    [Abstract] [Full Text] [Related]

  • 3. Emerging therapies for hepatitis C virus.
    Birerdinc A, Younossi ZM.
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):535-44. PubMed ID: 20629602
    [Abstract] [Full Text] [Related]

  • 4. New therapies for hepatitis C virus infection.
    Soriano V, Peters MG, Zeuzem S.
    Clin Infect Dis; 2009 Feb 01; 48(3):313-20. PubMed ID: 19123867
    [Abstract] [Full Text] [Related]

  • 5. How to use virological tools for the optimal management of chronic hepatitis C.
    de Leuw P, Sarrazin C, Zeuzem S.
    Liver Int; 2011 Jan 01; 31 Suppl 1():3-12. PubMed ID: 21205131
    [Abstract] [Full Text] [Related]

  • 6. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N, Marcellin P.
    Forum (Genova); 2000 Jan 01; 10(1):4-18. PubMed ID: 10717254
    [Abstract] [Full Text] [Related]

  • 7. Selective inhibitors of hepatitis C virus replication.
    Neyts J.
    Antiviral Res; 2006 Sep 01; 71(2-3):363-71. PubMed ID: 16843538
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus virology and new treatment targets.
    Meier V, Ramadori G.
    Expert Rev Anti Infect Ther; 2009 Apr 01; 7(3):329-50. PubMed ID: 19344246
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K, Kwo PY.
    Clin Liver Dis; 2009 Aug 01; 13(3):429-39. PubMed ID: 19628159
    [Abstract] [Full Text] [Related]

  • 11. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS, Jacobson IM.
    Clin Liver Dis; 2009 Aug 01; 13(3):441-52. PubMed ID: 19628160
    [Abstract] [Full Text] [Related]

  • 12. Treating HCV with ribavirin analogues and ribavirin-like molecules.
    Gish RG.
    J Antimicrob Chemother; 2006 Jan 01; 57(1):8-13. PubMed ID: 16293677
    [Abstract] [Full Text] [Related]

  • 13. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
    Welsch C, Jesudian A, Zeuzem S, Jacobson I.
    Gut; 2012 May 01; 61 Suppl 1():i36-46. PubMed ID: 22504918
    [Abstract] [Full Text] [Related]

  • 14. Future treatment of chronic hepatitis C.
    Keeffe EB.
    Antivir Ther; 2007 May 01; 12(7):1015-25. PubMed ID: 18018759
    [Abstract] [Full Text] [Related]

  • 15. [Direct antiviral treatment strategies in chronic hepatitis C].
    Neumann-Haefelin C, Blum HE, Thimme R.
    Dtsch Med Wochenschr; 2012 Jun 01; 137(25-26):1360-5. PubMed ID: 22653493
    [Abstract] [Full Text] [Related]

  • 16. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
    Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, Bonneau P, Bös M, Cameron DR, Cartier M, Cordingley MG, Faucher AM, Goudreau N, Kawai SH, Kukolj G, Lagacé L, LaPlante SR, Narjes H, Poupart MA, Rancourt J, Sentjens RE, St George R, Simoneau B, Steinmann G, Thibeault D, Tsantrizos YS, Weldon SM, Yong CL, Llinàs-Brunet M.
    Nature; 2003 Nov 13; 426(6963):186-9. PubMed ID: 14578911
    [Abstract] [Full Text] [Related]

  • 17. Improving anti-HCV therapy.
    Pol S, Mallet VO.
    Discov Med; 2006 Oct 13; 6(35):187-90. PubMed ID: 17234140
    [Abstract] [Full Text] [Related]

  • 18. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
    Chevaliez S.
    Clin Res Hepatol Gastroenterol; 2011 Dec 13; 35 Suppl 2():S46-51. PubMed ID: 22248694
    [Abstract] [Full Text] [Related]

  • 19. [Boceprevir: new possibilities for antiviral treatment of chronic hepatitis C].
    Nikitin IG, Baĭkova IE, Gogova LM, Volynkina VM, Kisliakov VA.
    Ter Arkh; 2013 Dec 13; 85(2):76-84. PubMed ID: 23653945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.